Upstart's 2.27% Drop and 288th Trading Rank Signal Earnings Uncertainty Amid Revised Forecasts and Institutional Sales

Generated by AI AgentAinvest Market Brief
Wednesday, Jul 30, 2025 4:33 am ET1min read
Aime RobotAime Summary

- Upstart's stock fell 2.27% to $80.43, ranking 288th in daily trading volume ahead of its August 5 earnings report.

- Analysts expect 258.8% YoY EPS growth and 76.5% revenue increase, but a -6.72% Zacks Earnings ESP revision signals reduced confidence.

- Institutional investors and CEO Dave Girouard sold shares, with the latter offloading $3.1M in holdings amid bearish sentiment.

- A high-volume trading strategy outperformed benchmarks with 166.71% returns since 2022, highlighting market volatility.

On July 29, 2025,

(UPST) closed with a 2.27% decline, trading at $80.43 with a $0.4 billion trading volume. The stock ranked 288th in daily trading activity, reflecting mixed investor sentiment ahead of its August 5 earnings report. Analysts anticipate quarterly earnings of $0.27 per share and $225.3 million in revenue, both showing year-over-year growth of 258.8% and 76.5%, respectively. However, recent bearish revisions to the Zacks Earnings ESP of -6.72% suggest analysts have scaled back expectations, complicating predictions of an earnings beat despite a Zacks Rank #3 (Hold).

Upstart’s earnings surprise history offers mixed signals. While it exceeded estimates by 57.89% in the prior quarter and outperformed four times in the last four quarters, the current bearish consensus and lack of a strong Zacks Rank diminish confidence in a positive surprise. Institutional activity further highlights uncertainty: Envestnet Asset Management reduced its stake by 16.1%, and CEO Dave Girouard sold 44.19% of his holdings, valued at over $3.1 million. These moves, coupled with a negative Earnings ESP, indicate cautious positioning ahead of the report.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day generated a 166.71% return from 2022 to the present, outperforming the 29.18% benchmark. With a 137.53% excess return, 31.89% CAGR, 0.00% maximum drawdown, and a Sharpe ratio of 1.14, the strategy demonstrated robust risk-adjusted performance and capital appreciation.

Comments



Add a public comment...
No comments

No comments yet